Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.2 DKK | +0.29% | +2.40% | -0.98% |
26/06 | Otsuka and Lundbeck's PTSD Treatment Moves Forward as FDA Accepts New Drug Application | MT |
25/06 | US FDA Accepts Lundbeck, Otsuka's New Drug Application for PTSD Combo Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.95% | 76.24B | |
+15.06% | 8.76B | |
0.00% | 8.17B | |
-33.62% | 6.63B | |
+2.13% | 4.13B | |
-9.75% | 3.8B | |
-9.46% | 3.32B | |
+7.77% | 3.2B | |
+7.37% | 3.19B |
- Stock Market
- Equities
- HLUN B Stock
- LUN Stock
- News Lundbeck
- Transcript : H. Lundbeck A/S Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-13-2014 09